Lewis Y (Tumor Marker) (A70-C/C8), 0.2mg/mL [26628-22-8]

Biotium

Lewis Y (Tumor Marker) (A70-C/C8), 0.2mg/mL [26628-22-8]

9

Research Use Only

Monoclonal

A70-C/C8

0.2 mg/ml

Mouse

IgM

This antibody recognizes a carbohydrate epitope common to the tumor-associated Lewis Y and Lewis b antigens (Fucalpha1-2Galbeta1-4/3GlcNAcbeta). Its specificity was established without doubt with a panel of 86 synthetic mono- and oligosaccharidic structures. Lewis Y is expressed in large bowel tumors and colorectal carcinomas. It may be useful in the classification of human renal and bladder tumors. The Lewis Y antigen has been evaluated as a clinical marker for the diagnosis and prognosis of cholangiocarcinoma, hepatocellular carcinoma and breast cancer.This antibody is available purified with BSA/azide at 200 ug/mL, or BSA/azide-free at 1 mg/mL.

Animal

Bovine, Human, Mouse

2°C to 8°C

12352203